Outlook Therapeutics (OTLK) Short Interest
Nasdaq • OTLK • US69012T3059
As of Oct 27, 2026, ORTEX estimated 20.3% of free float sold short, 8.2 days to cover, cost to borrow 3.44%. Sign up for live short interest data.
Nasdaq • OTLK • US69012T3059
As of Oct 27, 2026, ORTEX estimated 20.3% of free float sold short, 8.2 days to cover, cost to borrow 3.44%. Sign up for live short interest data.
This page tracks how heavily Outlook Therapeutics (Nasdaq:OTLK) is being shorted: ORTEX's daily short interest estimate, the cost to borrow the shares, utilization of the lendable supply and days to cover, next to the official exchange-reported figure.
Source: ORTEX. Some figures are limited on the free view; live data and full history are part of ORTEX Advanced.
Outlook Therapeutics (Nasdaq: OTLK) has a market capitalization of $117.1M. Last close $0.48 (as of 2026-11-12); 52-week range $0.16 to $2.54. ORTEX data as of 2026-10-27: short interest was 20.29% of free float, 8.2 days to cover and the average cost to borrow was 3.44%. Sign up for live short interest data.